SNDL
SNDL
NASDAQ · Pharmaceuticals

Sndl Inc

$1.35
-0.04 (-2.88%)
As of Mar 22, 10:25 PM ET ·
Financial Highlights (FY 2026)
Revenue
871.70M
Net Income
-89,771,764
Gross Margin
26.1%
Profit Margin
-10.3%
Rev Growth
+154.1%
D/E Ratio
0.13
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 26.1% 64.3% 64.3% 64.3%
Operating Margin -11.1% 39.1% 39.2% 39.7%
Profit Margin -10.3% 35.2% 27.9% 35.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 871.70M 64.47M 59.12M 71.20M
Gross Profit 227.60M 41.47M 38.02M 45.80M
Operating Income -96,845,519 25.21M 23.17M 28.28M
Net Income -89,771,764 22.72M 16.50M 24.90M
Gross Margin 26.1% 64.3% 64.3% 64.3%
Operating Margin -11.1% 39.1% 39.2% 39.7%
Profit Margin -10.3% 35.2% 27.9% 35.0%
Rev Growth +154.1% +0.6% +13.8% -7.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 21.34M 69.31M 55.29M 58.47M
Total Equity 158.80M 260.32M 239.97M 225.54M
D/E Ratio 0.13 0.27 0.23 0.26
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 2.15M 29.98M 25.74M 34.11M
Free Cash Flow 15.79M 14.78M 25.53M